| 0 (0%) | 04-07 10:11 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.45  |
1-year : | 4.04 |
| Resists | First : | 2.95 |
Second : | 3.46 |
| Pivot price | 2.75 |
|||
| Supports | First : | 2.15 | Second : | 1.78 |
| MAs | MA(5) : | 2.56 |
MA(20) : | 2.81 |
| MA(100) : | 5.8 |
MA(250) : | 14.49 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 11.1 |
D(3) : | 20.2 |
| RSI | RSI(14): 29.6  |
|||
| 52-week | High : | 174.6 | Low : | 2.15 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ FRMM ] has closed below the lower bollinger band by 6.3%. Bollinger Bands are 74% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 141 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.79 - 2.8 | 2.8 - 2.82 |
| Low: | 2.12 - 2.14 | 2.14 - 2.15 |
| Close: | 2.13 - 2.16 | 2.16 - 2.18 |
Tue, 07 Apr 2026
Forum Markets (FRMM) Receives New 'Speculative Buy' Rating from - GuruFocus
Tue, 07 Apr 2026
180 Life Sciences (FRMM) Stock Forecast and Price Target 2026 - MarketBeat
Tue, 07 Apr 2026
Top 180 Life Sciences (FRMM) Competitors 2026 - MarketBeat
Mon, 06 Apr 2026
FRMM Jun 2026 11.000 put (FRMM260618P00011000) Stock Historical Prices & Data - Yahoo! Finance Canada
Fri, 03 Apr 2026
FRMM SEC Filings - Forum Markets Incorporated 10-K, 10-Q, 8-K Forms - Stock Titan
Fri, 03 Apr 2026
Director at Forum Markets (FRMM) granted 241,918 restricted stock units - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 19 (M) |
| Held by Insiders | 1.431e+007 (%) |
| Held by Institutions | 30.2 (%) |
| Shares Short | 2,850 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2.2666e+008 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -5 % |
| Return on Assets (ttm) | 364.6 % |
| Return on Equity (ttm) | -27.8 % |
| Qtrly Rev. Growth | 4.11e+006 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -95.52 |
| EBITDA (p.s.) | 4.06931e+006 |
| Qtrly Earnings Growth | -182.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -19 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.03 |
| Price to Cash Flow | 0.08 |
| Dividend | 0 |
| Forward Dividend | 3e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|